| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |